Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

2.1K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.1K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

380
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
380
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

818
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
818
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

1.0K
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
1.0K
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

338
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
338
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

394
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
394

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and posttreatment results from a Phase 3 randomized trial.

Journal of hepatology·2026
Same author

The epidemiology of kidney and urinary tract infections in pediatric chronic kidney disease: prevalence, risk factors and association with GFR decline in the Chronic Kidney Disease in Children Study.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/Velpatasvir.

Viruses·2026
Same author

Patient triage for new appointments in medical dermatology may help decrease long waits for urgent and high-risk conditions: A multivariate retrospective analysis of factors associated with appointment lead times.

Journal of the American Academy of Dermatology·2026
Same author

Cardiovascular and Thromboembolic Events in Children and Adults With Glomerular Disease: Findings From the Cure GlomeruloNephropathy (CureGN) Network.

Kidney medicine·2025
Same author

Reassessing the Safety of Bulevirtide in Chronic Hepatitis Delta: A Critical Perspective.

Liver international : official journal of the International Association for the Study of the Liver·2025

Related Experiment Video

Updated: Apr 16, 2026

Use of a Hanging-weight System for Isolated Renal Artery Occlusion
07:54

Use of a Hanging-weight System for Isolated Renal Artery Occlusion

Published on: July 19, 2011

16.7K

Iohexol transmembrane clearance during modeled continuous renal replacement therapy.

J Michael Yardman-Frank, Renee-Claude Mercier, Craig S Wong

    Blood Purification
    |March 14, 2015
    PubMed
    Summary

    Continuous hemofiltration (CH) is more effective than continuous hemodialysis (CHD) at removing middle molecular weight solutes like iohexol. CH clearance of iohexol approximates the ultrafiltration rate, unlike CHD.

    More Related Videos

    Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
    06:23

    Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

    Published on: November 21, 2025

    701
    A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
    09:02

    A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

    Published on: February 2, 2021

    5.0K

    Related Experiment Videos

    Last Updated: Apr 16, 2026

    Use of a Hanging-weight System for Isolated Renal Artery Occlusion
    07:54

    Use of a Hanging-weight System for Isolated Renal Artery Occlusion

    Published on: July 19, 2011

    16.7K
    Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
    06:23

    Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

    Published on: November 21, 2025

    701
    A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
    09:02

    A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

    Published on: February 2, 2021

    5.0K

    Area of Science:

    • Nephrology
    • Renal Replacement Therapy
    • Solute Kinetics

    Background:

    • Urea clearance inadequately represents middle molecular weight solute removal during continuous renal replacement therapy (CRRT).
    • Iohexol (821 Da) serves as a model for middle molecular weight solutes.

    Purpose of the Study:

    • To characterize iohexol clearance during continuous hemofiltration (CH) and continuous hemodialysis (CHD).
    • To compare the efficacy of CH and CHD in removing middle molecular weight solutes.

    Main Methods:

    • In vitro model utilizing the M100 membrane.
    • Determination of iohexol sieving coefficients (SC) and saturation coefficients (SA).
    • Assessment at varying ultrafiltration/dialysate rates (1-6 L/h).

    Main Results:

    • CH demonstrated consistent iohexol SC near 1 across all tested ultrafiltration rates.
    • CHD showed a significant decrease in iohexol SA from 1.02 at 1 L/h to 0.57 at 6 L/h dialysate rate.
    • Iohexol transmembrane clearance in CH approximated the ultrafiltration rate.

    Conclusions:

    • Continuous hemofiltration is more effective for iohexol removal than continuous hemodialysis at higher effluent flow rates.
    • CH offers predictable middle molecular weight solute clearance based on ultrafiltration rate.